Global Information
회사소개 | 문의 | 비교리스트

세계의 다낭성 난소 증후군(PCOS) 치료 시장 : 예측과 기회(-2025년)

Global PCOS Treatment Market By Treatment, By Diagnosis, By End User, By Region, Forecast & Opportunities, 2025

리서치사 TechSci Research
발행일 2020년 05월 상품 코드 934757
페이지 정보 영문 113 Pages
가격
US $ 4,450 ₩ 5,119,000 Unprintable PDF and Excel (Single User License)
US $ 5,450 ₩ 6,270,000 PDF and Excel (Multi-User License)
US $ 9,450 ₩ 10,872,000 PDF and Excel (Custom Research License)

TechSci Research 보고서는 10% Customization 서비스가 포함되어 있습니다. 보고서에 포함돼 있지 않은 리서치 데이터와 시장 동향을 추가적으로 요청할 수 있습니다. 자세한 사항은 문의하여 주시기 바랍니다.



세계의 다낭성 난소 증후군(PCOS) 치료 시장 : 예측과 기회(-2025년) Global PCOS Treatment Market By Treatment, By Diagnosis, By End User, By Region, Forecast & Opportunities, 2025
발행일 : 2020년 05월 페이지 정보 : 영문 113 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계 다낭성 난소 증후군(PCOS) 치료 시장은 예측기간 동안 놀라운 속도로 성장할 것입니다. 세계 PCOS 치료 시장은 여성의 당뇨병과 비만 유병률 증가에 힘입어 성장하고 있습니다. 또한 여성 호르몬 불균형 증례 증가가 시장 성장을 가속할 것으로 예상됩니다.

세계의 다낭성 난소 증후군(PCOS) 치료 시장을 부문/지역별로 조사했으며, 시장 규모 및 시장 점유율 예측, 성장 촉진요인과 과제, 시장 동향, 경쟁 상황, 기업 프로파일 등의 정보를 전해드립니다.

목차

제1장 제품 개요

제2장 조사 방법

제3장 코로나19(COVID-19)가 세계 PCOS 치료 시장에 미치는 영향

제4장 개요

제5장 고객의 견해

  • 브랜드 인지도
  • 제품 인식
  • 고객 만족도 분석
  • 충족되지 않은 욕구와 과제

제6장 세계의 다낭성 난소 증후군(PCOS) 치료 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
    • 치료별(수술, 약물 치료)
    • 진단별(골반검사, 초음파, 혈액검사)
    • 최종사용자별(병원 및 클리닉, 외래수술센터(ASC), 불임치료 클리닉)
    • 기업별(2019년)
    • 지역별
  • 제품 시장 맵

제7장 아시아태평양의 다낭성 난소 증후군(PCOS) 치료 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
    • 치료별
    • 진단별
    • 최종사용자별
    • 국가별
  • 아시아태평양 : 국가 분석
    • 중국
    • 인도
    • 호주
    • 일본
    • 한국

제8장 유럽의 다낭성 난소 증후군(PCOS) 치료 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
    • 치료별
    • 진단별
    • 최종사용자별
    • 국가별
  • 유럽 : 국가 분석
    • 프랑스
    • 독일
    • 영국
    • 이탈리아
    • 스페인

제9장 북미의 다낭성 난소 증후군(PCOS) 치료 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
    • 치료별
    • 진단별
    • 최종사용자별
    • 국가별
  • 북미 : 국가 분석
    • 미국
    • 멕시코
    • 캐나다

제10장 남미의 다낭성 난소 증후군(PCOS) 치료 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
    • 치료별
    • 진단별
    • 최종사용자별
    • 국가별
  • 남미 : 국가 분석
    • 브라질
    • 아르헨티나
    • 콜롬비아

제11장 중동 및 아프리카의 다낭성 난소 증후군(PCOS) 치료 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
    • 치료별
    • 진단별
    • 최종사용자별
    • 국가별
  • 중동 및 아프리카 : 국가 분석
    • 남아프리카공화국
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 쿠웨이트

제12장 시장 역학

  • 성장 촉진요인
  • 과제

제13장 시장 동향과 발전

제14장 임상시험

제15장 경쟁 상황

  • Bristol-Myers Squibb Company
  • Bayer AG
  • Pfizer, Inc.
  • Abbott Laboratories
  • Merck & Co., Inc.
  • Sanofi SA
  • AstraZeneca Plc
  • Novartis AG
  • Teva Pharmaceutical Industries Limited
  • Ferring Pharmaceuticals, Inc.
  • Neurocrine Biosciences, Inc.
  • EffRx Pharmaceuticals SA
  • Mylan NV
  • Millendo Therapeutics, Inc.

제16장 전략적 권장사항

제17장 면책조항

LSH 20.06.05

Global PCOS treatment market is expected to grow at a formidable rate during the forecast period. The global PCOS treatment market is driven by the increasing prevalence of diabetes and obesity among the woman population. Additionally, increasing cases of hormonal imbalances in the women are further expected to propel the market during forecast period. Furthermore, ongoing technological advancements and new product launches by the major players operating in the market for the development of new drugs and treatment options are anticipated to foster the growth of market through 2025.

The global PCOS treatment market is segmented based on treatment, diagnosis, end user, company and region. Based on treatment the market can be bifurcated into surgeries and drug treatment. The surgeries segment can further be categorized into ovarian wedge resection and laparoscopic ovarian drilling. The laparoscopic ovarian drilling segment is expected to dominate the market during forecast years. This can be attributed to the fertility problems faced by the women due to this problem and the response to medications generally weakens over time in women. Additionally, this procedure is cost effective and easy to perform which is driving the growth of segment across the globe.

Regionally, the global PCOS treatment market has been segmented into Asia-Pacific, North America, South America, Europe, and Middle East & Africa. Among these, North America is expected to witness significant growth during the forecast years in the global PCOS treatment market owing to the growing prevalence of overweight and obese women population in the region.

Major players operating in the global PCOS treatment market include Bristol-Myers Squibb Company, Bayer AG, Pfizer, Inc., Abbott Laboratories, Merck & Co., Inc., Sanofi SA, AstraZeneca Plc, Novartis AG, Teva Pharmaceutical Industries Limited, Ferring Pharmaceuticals, Inc., Neurocrine Biosciences, Inc., EffRx Pharmaceuticals SA, Mylan N.V., Millendo Therapeutics, Inc. and others. The companies are developing advanced technologies and launching new services in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new product developments.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021-2025

Objective of the Study

  • To analyze and estimate the market size of global PCOS treatment market from 2015 to 2018.
  • To estimate and forecast the market size of global PCOS treatment market from 2019 to 2025 and growth rate until 2025.
  • To classify and forecast global PCOS treatment market based on treatment, diagnosis, end user, company and regional distribution.
  • To identify dominant region or segment in the global PCOS treatment market.
  • To identify drivers and challenges for global PCOS treatment market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global PCOS treatment market.
  • To identify and analyze the profile of leading players operating in global PCOS treatment market.
  • To identify key sustainable strategies adopted by market players in global PCOS treatment market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of hospitals & clinics, ambulatory surgical centers, fertility clinics across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the hospitals & clinics, ambulatory surgical centers, fertility clinics which could not be identified due to the limitations of secondary research. TechSci Research analyzed the hospitals & clinics, ambulatory surgical centers, fertility clinics and presence of all major players across the globe.

TechSci Research calculated the market size of global PCOS treatment market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience

  • PCOS treatment hospitals & clinics, ambulatory surgical centers, fertility centers and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to PCOS treatment
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as hospitals & clinics, ambulatory surgery centers, fertility clinics, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope

In this report, global PCOS treatment market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global PCOS Treatment Market, By Treatment:

Surgeries

  • Ovarian Wedge Resection
  • Laparoscopic Ovarian Drilling

Drug Treatment

  • Oral Contraceptives
  • Antiandrogens
  • Anti-Depressants
  • Anti-Obesity Drugs
  • Others
  • Global PCOS Treatment Market, By Diagnosis:

Pelvic Examination

Ultrasound

Blood Tests

  • Global PCOS Treatment Market, By End User:

Hospitals & Clinics

Ambulatory Surgical Centers

Fertility Clinics

  • Global PCOS Treatment Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain

Asia-Pacific

  • China
  • Japan
  • India
  • South Korea
  • Australia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

South America

  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global PCOS treatment market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global PCOS Treatment Market

4. Executive Summary

5. Voice of Customer

  • 5.1. Brand Awareness (Aided/Unaided)
  • 5.2. Product Awareness
  • 5.3. Customer Satisfaction Analysis
  • 5.4. Unmet Needs/Challenges

6. Global PCOS Treatment Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Treatment (Surgeries v/s Drug Treatment)
      • 6.2.1.1. By Surgeries (Ovarian Wedge Resection, Laparoscopic Ovarian Drilling)
      • 6.2.1.2. By Drug Treatment (Oral Contraceptives, Antiandrogens, Anti-Depressants, Insulin-Sensitizing Agents, Anti-Obesity Drugs, Others)
    • 6.2.2. By Diagnosis (Pelvic Examination, Ultrasound, Blood Tests)
    • 6.2.3. By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Fertility Clinics)
    • 6.2.4. By Company (2019)
    • 6.2.5. By Region
  • 6.3. Product Market Map

7. Asia-Pacific PCOS Treatment Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Treatment
    • 7.2.2. By Diagnosis
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Asia-Pacific: Country Analysis
    • 7.3.1. China PCOS Treatment Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Treatment
        • 7.3.1.2.2. By Diagnosis
        • 7.3.1.2.3. By End User
    • 7.3.2. India PCOS Treatment Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Treatment
        • 7.3.2.2.2. By Diagnosis
        • 7.3.2.2.3. By End User
    • 7.3.3. Australia PCOS Treatment Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Treatment
        • 7.3.3.2.2. By Diagnosis
        • 7.3.3.2.3. By End User
    • 7.3.4. Japan PCOS Treatment Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Treatment
        • 7.3.4.2.2. By Diagnosis
        • 7.3.4.2.3. By End User
    • 7.3.5. South Korea PCOS Treatment Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Treatment
        • 7.3.5.2.2. By Diagnosis
        • 7.3.5.2.3. By End User

8. Europe PCOS Treatment Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Treatment
    • 8.2.2. By Diagnosis
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France PCOS Treatment Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Treatment
        • 8.3.1.2.2. By Diagnosis
        • 8.3.1.2.3. By End User
    • 8.3.2. Germany PCOS Treatment Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Treatment
        • 8.3.2.2.2. By Diagnosis
        • 8.3.2.2.3. By End User
    • 8.3.3. United Kingdom PCOS Treatment Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Treatment
        • 8.3.3.2.2. By Diagnosis
        • 8.3.3.2.3. By End User
    • 8.3.4. Italy PCOS Treatment Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Treatment
        • 8.3.4.2.2. By Diagnosis
        • 8.3.4.2.3. By End User
    • 8.3.5. Spain PCOS Treatment Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Treatment
        • 8.3.5.2.2. By Diagnosis
        • 8.3.5.2.3. By End User

9. North America PCOS Treatment Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Treatment
    • 9.2.2. By Diagnosis
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. North America: Country Analysis
    • 9.3.1. United States PCOS Treatment Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Treatment
        • 9.3.1.2.2. By Diagnosis
        • 9.3.1.2.3. By End User
    • 9.3.2. Mexico PCOS Treatment Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Treatment
        • 9.3.2.2.2. By Diagnosis
        • 9.3.2.2.3. By End User
    • 9.3.3. Canada PCOS Treatment Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Treatment
        • 9.3.3.2.2. By Diagnosis
        • 9.3.3.2.3. By End User

10. South America PCOS Treatment Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Treatment
    • 10.2.2. By Diagnosis
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil PCOS Treatment Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Treatment
        • 10.3.1.2.2. By Diagnosis
        • 10.3.1.2.3. By End User
    • 10.3.2. Argentina PCOS Treatment Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Treatment
        • 10.3.2.2.2. By Diagnosis
        • 10.3.2.2.3. By End User
    • 10.3.3. Colombia PCOS Treatment Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Treatment
        • 10.3.3.2.2. By Diagnosis
        • 10.3.3.2.3. By End User

11. Middle East and Africa PCOS Treatment Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Treatment
    • 11.2.2. By Diagnosis
    • 11.2.3. By End User
    • 11.2.4. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa PCOS Treatment Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Treatment
        • 11.3.1.2.2. By Diagnosis
        • 11.3.1.2.3. By End User
    • 11.3.2. Saudi Arabia PCOS Treatment Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Treatment
        • 11.3.2.2.2. By Diagnosis
        • 11.3.2.2.3. By End User
    • 11.3.3. UAE PCOS Treatment Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Treatment
        • 11.3.3.2.2. By Diagnosis
        • 11.3.3.2.3. By End User
    • 11.3.4. Kuwait PCOS Treatment Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Treatment
        • 11.3.4.2.2. By Diagnosis
        • 11.3.4.2.3. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Clinical Trials

15. Competitive Landscape

  • 15.1. Bristol-Myers Squibb Company
  • 15.2. Bayer AG
  • 15.3. Pfizer, Inc.
  • 15.4. Abbott Laboratories
  • 15.5. Merck & Co., Inc.
  • 15.6. Sanofi SA
  • 15.7. AstraZeneca Plc
  • 15.8. Novartis AG
  • 15.9. Teva Pharmaceutical Industries Limited
  • 15.10. Ferring Pharmaceuticals, Inc.
  • 15.11. Neurocrine Biosciences, Inc.
  • 15.12. EffRx Pharmaceuticals SA
  • 15.13. Mylan N.V.
  • 15.14. Millendo Therapeutics, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer

Back to Top
전화 문의
F A Q